Zimbabwe has rejected a major US health deal valued at $367m (272 million pounds) over five years over the United States' insistence on sensitive information.
This rejection became public after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official spokesperson later explained that the United States was seeking genetic material for scientific study and commercial purposes while refused to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged further dialogue to find a deal acceptable to both sides so the nation's critical HIV programme can proceed.
Broader Background
This rejection follows a similar case in neighbouring Kenya, where a court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance transparency and accountability.
Based on statements, Sixteen African countries have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Deal
The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to provide its biological resources and data for a long time, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our country would provide the basic resources for medical research without any assurance that the final treatments would be available to our population should a new disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures already established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how subsequent co-operation might be arranged in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts said it acknowledged the official position, but recommended that talks must proceed since much of the country's HIV programmes depended on international support.
"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
The situation underscores the ongoing challenges between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.